BACKGROUND: The COVID-19 pandemic may have caused an underestimation of cardiovascular disease (CVD) mortality, as COVID-19 was predominantly recorded as the underlying cause of death. This study investigates CVD-related excess mortality and recording of CVD on the death certificates during 2020-2021, considering underlying (underlying causes of death (UCD)), immediate and contributory causes. METHODS: We utilize US Multiple-Cause-of-Death Mortality Data. Excess deaths are assessed by comparing actual 2020-2021 deaths with Seasonal Autoregressive Integrated Moving Average model predictions. To understand changes in cause-of-death recording, we use the standardized ratio of multiple to underlying causes (SRMU). RESULTS: Excess CVD mortality is most prominent in contributory causes, including hypertensive disease, essential hypertension, and acute myocardial infarction. While excess of contributory CVDs generally decreased in 2021, acute myocardial infarction, pulmonary heart diseases and other circulatory diseases showed a continual increase. Changes in SRMU from 2020 to 2021, compared to 2010-2019, reveal shifts in coding practices, particularly for pulmonary heart, cerebrovascular diseases, non-rheumatic valve disorders and heart failure. CONCLUSIONS: The COVID-19 pandemic has significantly increased CVD-related mortality, which is not fully captured in conventional analyses based solely on the UCD. The trend of coding CVDs as non-underlying causes of death accelerated during 2020-2021. Multiple-causes-of-death should be employed to evaluate mortality when new leading cause of death emerges.

Department of Demography and Geodemography Faculty of Science Charles University Prague 12800 Czech Republic

J Public Health (Oxf). 2024 May 29;46(2):302. doi: 10.1093/pubmed/fdae034. PubMed

Zobrazit více v PubMed

Han  L, Zhao  S, Li  S. et al.  Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022. Nat Cardiovasc Res  2023;2(3):322–33. PubMed

Banerjee  A, Chen  S, Pasea  L. et al.  Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol  2021;28(14):1599–609. PubMed PMC

Brant  LCC, Nascimento  BR, Teixeira  RA. et al.  Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities. Heart  2020;106(24):1898–905. PubMed

Wadhera  RK, Shen  C, Gondi  S. et al.  Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol  2021;77(2):159–69. PubMed PMC

Bansal  M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr  2020;14(3):247–50. PubMed PMC

Paramasivam  A, Priyadharsini  JV, Raghunandhakumar  S. et al.  A novel COVID-19 and its effects on cardiovascular disease. Hypertens Res  2020;43(7):729–30. PubMed PMC

Gori  T, Lelieveld  J, Münzel  T. Perspective: cardiovascular disease and the Covid-19 pandemic. Basic Res Cardiol  2020;115:32–4. PubMed PMC

Pepera  G, Tribali  M-S, Batalik  L. et al.  Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Rev Cardiovasc Med  2022;23(1):28. PubMed

Wang  QQ, Davis  PB, Gurney  ME. et al.  COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement  2021;17(8):1297–306. PubMed PMC

Fedeli  U, Casotto  V, Schievano  E. et al.  Diabetes as a cause of death across different COVID-19 epidemic waves. Diabetes Res Clin Pract  2022;190:109984. PubMed PMC

Basso  C, Barbiellini Amidei  C, Casotto  V. et al.  Veneto Region dementia-related mortality during the COVID-19 pandemic: multiple causes of death and time series analysis. Eur J Public Health  2023;33(2):190–5. PubMed PMC

Shiels  MS, Haque  AT, Berrington de González  A. et al.  Leading causes of death in the US during the COVID-19 pandemic, March 2020 to October 2021. JAMA Intern Med  2022;182(8):883–6. PubMed PMC

Vasconcelos  AMN, Ishitani  L, Abreu  DMX. et al.  Covid adult mortality in Brazil: an analysis of multiple causes of death. Front Public Health  2022;9:788932. PubMed PMC

NBER , 2023. Multiple mortality data vital statistics. https://www.nber.org/research/data/mortality-data-vital-statistics-nchs-multiple-cause-death-data.

NCHS , 2023. Multiple mortality public use data. https://www.cdc.gov/nchs/nvss/mortality_public_use_data.htm.

WHO , 2021. Classification of diseases. https://www.who.int/standards/classifications/classification-of-diseases/cause-of-death.

Chamblee  RF. TRANSAX: The NCHS system for producing multiple cause-of-death statistics 1968-78. Vital Health Stat 1  1986;20:1–83. PubMed

Human Mortality Database. University of California; Berkeley (USA); and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (2 March 2023 date last accessed).

Janssen  TA. Importance of tabulating multiple causes of death. Am J Public Health Nations Health  1940;30(8):871–9. PubMed PMC

Kendall, ORD  JK. Time Series, 3rd edn. Seven Oaks: Arnold, 1990.

Chatfield  C, Xing  H. The Analysis of Time Series: An Introduction with R. Boca Raton: CRC press, 2019.

Hamilton  JD. Time Series Analysis. Princeton: Princeton university press, 2020.

Perone  G. Using the SARIMA model to forecast the fourth global wave of cumulative deaths from COVID-19: Evidence from 12 hard-hit big countries. Econometrics  2022;10(2):18.

Clarke  BS, Clarke  JL. Predictive Statistics: Analysis and Inference Beyond Models. Vol. 46. Cambrigde: Cambridge University Press, 2018.

Bishop  K, Moreno-Betancur  M, Balogun  S. et al.  Quantifying cause-related mortality in Australia, incorporating multiple causes: observed patterns, trends and practical considerations. Int J Epidemiol  2023;52(1):284–94. PubMed PMC

Box  GEP, Jenkins  GM, Reinsel  GC. et al.  Time Series Analysis: Forecasting and Control. Holden Day: John Wiley & Sons, 2015.

WHO (WHO 2000–2025) Standard Population. https://seer.cancer.gov/stdpopulations/ (10 July 2023 date last accessed).